Glenmark Pharmaceuticals Inc., USA recalls Trandolapril and Verapamil Hydrochloride Extended-Release Tablets 2 mg / 180 mg, 100-count Bottle, Rx only, Manufactured by:…
Subpotent: Out of Specification for Assay Test at the 3-month time point.
Read the official notice →- Date
- 2023-08-30
- Country
- United States
- Brand
- Glenmark Pharmaceuticals
- Product
- Trandolapril and Verapamil Hydrochloride Extended-Release Tablets 2 mg / 180 mg, 100-count Bottle, Rx only, Manufactured by: Glenmark…
- Classification
- Class III
- Units
- nationwide in the U.S.
- Category
- Drugs & medical
- Source
- FDA · Drug
Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the product name, strength and lot number against the official notice.
- Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
- Ask the pharmacy or supplier about a replacement or refund.
General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.
More Glenmark Pharmaceuticals recalls
- 2023-11-15
US- US
Glenmark Pharmaceuticals Inc., USA recalls Ranolazine Extended-Release Tablets 500mg, 60 Tablets per bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited,…
Failed Dissolution Specifications: Out of specification for dissolution.
- 2023-11-08
- US
Glenmark Pharmaceuticals Inc., USA recalls Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP, 5mg/6.25mg, 100-count Bottle, RX only, Manufactured by: Glenmark…
Failed Impurities/Degradation Specifications
- 2022-08-17
- US
Glenmark Pharmaceuticals Inc., USA recalls Telmisartan and Hydrochlorothiazide Tablets USP, 80 mg/25 mg, 30 Tablets, Rx Only, Manufactured by: Glenmark Pharmaceuticals…
Defective Container: Recall of these batches has been initiated due to complaints of difficult to open blister and tablet breaks while opening the blister .
- 2022-08-10
- US
Glenmark Pharmaceuticals Inc., USA recalls Tacrolimus Ointment, 0.1%, For Dermatological Use Only, Not for Ophthalmic Use, Rx Only, a) 30 g tube, NDC 68462-534-35, b)…
Defective Container: Tube split from side seam
- 2022-07-27
- US
Glenmark Pharmaceuticals Inc., USA recalls Aspirin and Extended-Release Dipyridamole Capsules, 25mg/200 mg, 60-count bottle, Rx Only, Manufactured for: Glenmark…
Failed Tablet/Capsule Specification : Capsule breakage
Other drugs & medical recalls in the United States
- 2023-08-30
- US
Inmar Supply Chain Solutions, LLC recalls All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar.
CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center. Also, due to unusually hot weather, FDA Recalled Products may have been subjected to temperatures in excess of storage…
FDA · DrugInmar Supply Chain Solutions, LLCSeparate Distribution List (salvage buyers) provided by Inmar and will be…Official notice → - US
Baxter Healthcare Corporation recalls Bendamustine HCl Injection, 100mg/4mL (25mg/mL), One 4 mL Multiple-Dose Vial, Rx only, Manufactured for Baxter Healthcare…
Labeling: Missing Label; customer complaint received that labels were partially or completely peeled off injection vial.
- US
Ecometics, Inc. recalls activator concentrate, Sodium Fluoride 0.96% in Activator Concentrate; 0.08% in diluted Activator Solution, Net 1 FL. OZ., Manufactured…
CGMP Deviations: Products not manufactured under current good manufacturing practices.
- US
Imprimis NJOF, LLC recalls Moxifloxacin - Bromfenac Sterile Ophthalmic Solution 0.5% / 0.075%, 5mL bottle, Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B,…
Subpotent Drug; sub-potent Bromfenac levels, below the 90.0-110.0% specification range.
- US
Parker Laboratories, Inc. recalls Helix Pain Relieving Cream (Menthol 7.4%), packaged in a) 5 gm pouch (NDC 30775-051-01), b) 3 fl. oz. roll-on (NDC 30775-051-03), c) 4…
CGMP Deviations
FDA · DrugParker Laboratories, Inc.Nationwide within the United States, Singapore, Korea and Hong KongOfficial notice → - US
Aurobindo Pharma USA Inc. recalls Rufinamide Tablets, USP 400 mg, packaged in 120-count bottle, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279…
cGMP deviations: Batch was released prior to approval.